The groundbreaking approach of the medication represents a major breakthrough in the management of type 2 diabetes. Unlike existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide502992.bloggerchest.com/42151562/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment